A biological crop protection solution using novel plant growth regulators derived from soil microbes to selectively suppress pathogens like Fusarium and Phytophthora while promoting beneficial plant-microbe interactions. Enables disease resistance without soil fumigation or resistant cultivars, with scalable production via automated bioreactors.
This microbiome engineering platform addresses one of agriculture's most persistent challenges: soil-borne crop diseases caused by pathogens such as Fusarium and Phytophthora. Traditional control methods rely on soil fumigation or resistant cultivars, both of which have significant limitations in cost, sustainability, and effectiveness.
The approach leverages naturally occurring bioactive compounds produced by soil microbes that act as plant growth regulators. These compounds enable plants to distinguish between harmful pathogens and beneficial microbes, triggering natural defense responses against pathogens while enhancing growth-promoting interactions with helpful microbes. Simple application of these compounds to soil has demonstrated both disease resistance and improved plant growth across horticultural and cereal crops.
Core technology:
Key benefits:
The technology has achieved proof-of-concept validation in controlled settings, demonstrating durable resistance against Fusarium and Phytophthora in several horticultural and cereal crops. Microbial production capabilities are established through automated bioreactor systems.
Next-stage validation will focus on farm-scale testing across diverse crops and soil types affected by hard-to-control pests and pathogens. This will confirm crop quality safety, validate the biological approach at commercial scale, and refine the proprietary microencapsulation delivery system for practical field deployment.
The University of Queensland is a large, multi-campus public research university in Brisbane with a comprehensive academic and research profile. Industry partners engage through hospital-embedded laboratories and clinical sites, pilot testbeds, and field campuses across Queensland that enable prototyping, trials, and validation in real-world settings. Co-location with major health precincts and proximity to Brisbane’s innovation districts make collaboration and talent access straightforward, while on-campus incubation and professional education support workforce upskilling. Research is supported by competitive national funding from the Australian Research Council and the National Health and Medical Research Council, alongside state and industry investment. A dedicated technology transfer office and commercialization company manage IP, licensing, sponsored research agreements, and spin-out formation.